{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:41:49Z","timestamp":1790379709669,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.lpm.2018.05.013","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T02:41:49Z","timestamp":1532054509000},"page":"655-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["H\u00e9patite alcoolique aigu\u00eb s\u00e9v\u00e8re"],"prefix":"10.1016","volume":"47","author":[{"given":"Eric","family":"Nguyen-Khac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Dejour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Sarba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Yzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Chatelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Marcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Chivot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Antoine","family":"Papillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Attencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Houchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2018.05.013_bib0005","article-title":"EASL Clinical Practice Guidelines: management of alcohol-related liver, disease. European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.lpm.2018.05.013_bib0010","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2018.05.013_bib0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","article-title":"Enteric dysbiosis associated with a mouse model of alcoholic liver disease","volume":"53","author":"Yan","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lpm.2018.05.013_bib0030","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1038\/s41598-018-23146-3","article-title":"Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis","volume":"8","author":"Ciocan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.lpm.2018.05.013_bib0035","first-page":"178","article-title":"Ethanol induced changes in glycosylation of mucins in rat intestine","volume":"22","author":"Grewal","year":"2009","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0040","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3945\/jn.110.135657","article-title":"Regulation of tight junction permeability by intestinal bacteria and dietary components","volume":"141","author":"Ulluwishewa","year":"2011","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.lpm.2018.05.013_bib0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2018.05.013_bib0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.510230121","article-title":"Role of cytochromeP4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol","volume":"23","author":"Albano","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep.1840160619","article-title":"Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats","volume":"16","author":"Hirano","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/jn\/128.4.758","article-title":"Chronic ethanol consumption affects glutathione status in rat liver","volume":"128","author":"Oh","year":"1998","journal-title":"J Nutr"},{"key":"10.1016\/j.lpm.2018.05.013_bib0065","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0016-5085(98)70034-4","article-title":"Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor","volume":"115","author":"Colell","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.1840200227","article-title":"Inactivation of Kupffer cells prevents early alcohol-induced liver injury","volume":"20","author":"Adachi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0075","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/jhep.2000.19621","article-title":"Exacerbation of alcoholic liver injury by enteral endotoxin in rats","volume":"32","author":"Mathurin","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0080","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1530-0277.1995.tb00969.x","article-title":"Cellular signals in alcohol-induced liver injury: a review","volume":"19","author":"Lands","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.lpm.2018.05.013_bib0085","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2007.01.053","article-title":"Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice","volume":"132","author":"Pritchard","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0090","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","article-title":"Essential role of tumor necrosis factor in alcohol-induced liver injury in mice","volume":"117","author":"Yin","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0095","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1530-0277.2010.01399.x","article-title":"Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines","volume":"35","author":"Miller","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.lpm.2018.05.013_bib0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1530-0277.1981.tb04890.x","article-title":"Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans","volume":"5","author":"Hrubec","year":"1981","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.lpm.2018.05.013_bib0105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1530-0277.2008.00629.x","article-title":"The -308\u00a0TNF gene polymorphism in severe acute alcoholic hepatitis: identification of a new susceptibility marker","volume":"32","author":"Nguyen-Khac","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.lpm.2018.05.013_bib0110","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1530-0277.1996.tb01695.x","article-title":"Genetic disposition to organ-specific endpoints of alcoholism","volume":"20","author":"Reed","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.lpm.2018.05.013_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","article-title":"Variant in PNPLA3\u00a0is associated with alcoholic liver disease","volume":"42","author":"Tian","year":"2010","journal-title":"Nat Genet"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.lpm.2018.05.013_bib0120","first-page":"1308","article-title":"Is PNPLA3\u00a0polymorphism involved in severe acute alcoholic hepatitis?","volume":"54","author":"Nguyen-Khac","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2018.05.013_bib0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0145","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.3748\/wjg.v12.i25.4020","article-title":"Predicting utility of a model for end stage liver disease in alcoholic liver disease","volume":"12","author":"Soultati","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0150","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2018.05.013_bib0155","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2018.05.013_bib0160","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0165","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ajg.2009.645","article-title":"Comparison of the Glasgow alcoholic hepatitis score and the ABIC score for the assessment of alcoholic hepatitis","volume":"105","author":"Forrest","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.lpm.2018.05.013_bib0175","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"CANONIC Study Investigators of the EASL\u2013CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.lpm.2018.05.013_bib0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2016.10.012","article-title":"Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis","volume":"66","author":"Arroyo","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0185","article-title":"The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis","author":"Serst\u00e9","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0190","doi-asserted-by":"crossref","first-page":"A233","DOI":"10.1136\/gut.2011.239301.492","article-title":"Is histology required for the diagnosis of alcoholic hepatitis: a review of published randomized controlled trials","volume":"60","author":"Hamid","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2018.05.013_bib0195","first-page":"303","article-title":"Pathological spectrum of alcoholic liver disease","volume":"2","author":"Hall","year":"1994","journal-title":"Alcohol Alcohol Suppl"},{"key":"10.1016\/j.lpm.2018.05.013_bib0200","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"issue":"Suppl.\u00a02bis","key":"10.1016\/j.lpm.2018.05.013_bib0205","first-page":"A231","article-title":"Int\u00e9r\u00eat de la biopsie h\u00e9patique\u00a0: pour la s\u00e9lection des sujets suspects d\u2019h\u00e9patite alcoolique s\u00e9v\u00e8re","volume":"16","author":"Mathurin","year":"1992","journal-title":"Gastroenterol Clin Biol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.lpm.2018.05.013_bib0210","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1016\/S0168-8278(10)61153-1","article-title":"Severe acute alcoholic hepatitis in France (AAH) in 2008: a nationwide survey results (AFEF, ANGH, SNFMI)","volume":"52","author":"Nguyen-Khac","year":"2010","journal-title":"J Hepatol"},{"issue":"Suppl.","key":"10.1016\/j.lpm.2018.05.013_bib0215","first-page":"651","article-title":"Evaluation and management of alcoholic hepatitis: a survey of current practices [abstract]","volume":"50","author":"Ahn","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0220","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/00365528309181659","article-title":"The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis","volume":"18","author":"Kryger","year":"1983","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0225","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jhep.2006.02.010","article-title":"The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease","volume":"44","author":"Thabut","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0230","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0168-8278(00)80391-8","article-title":"Serum laminin and type IV collagen are accurate markers of histolo- gically severe alcoholic hepatitis in patients with cirrhosis","volume":"32","author":"Castera","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0235","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2018.05.013_bib0240","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/0148607195019004258","article-title":"Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group","volume":"19","author":"Mendenhall","year":"1995","journal-title":"J Parenter Enteral Nutr"},{"key":"10.1016\/j.lpm.2018.05.013_bib0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clnu.2006.01.018","article-title":"ESPEN guidelines on enteral nutrition: liver disease","volume":"25","author":"Plauth","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1016\/j.lpm.2018.05.013_bib0250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0255","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0260","first-page":"208","article-title":"Treatment of acute alcoholic hepatitis","volume":"2","author":"Reynolds","year":"1989","journal-title":"Gastroenterol Int"},{"key":"10.1016\/j.lpm.2018.05.013_bib0265","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis? A metaanalysis of the randomized trials","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2018.05.013_bib0270","first-page":"223","article-title":"Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis","volume":"15","author":"Daures","year":"1991","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.lpm.2018.05.013_bib0280","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0285","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis. a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lpm.2018.05.013_bib0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.lpm.2018.05.013_bib0295","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0300","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28\u00a0days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0305","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for & alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lpm.2018.05.013_bib0310","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2013a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0315","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0320","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.lpm.2018.05.013_bib0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jhep.2008.04.003","article-title":"Antioxidants plus corticosteroids in the treatment of severe acute alcoholic hepatitis: the question is still open","volume":"49","author":"Nguyen-Khac","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0330","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2018.05.013_bib0335","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0340","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","article-title":"Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis","volume":"138","author":"Lebrec","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0345","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4254\/wjh.v3.i8.205","article-title":"Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: current status","volume":"3","author":"Singal","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0350","first-page":"20","article-title":"Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial","volume":"60","author":"Sidhu","year":"2012","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.lpm.2018.05.013_bib0355","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s10620-012-2097-4","article-title":"Corticosteroid plus pentoxifylline is not better than corticosteroidalone for improving survival in severe alcoholic hepatitis (COPE trial)","volume":"57","author":"Sidhu","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.lpm.2018.05.013_bib0360","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2018.05.013_bib0365","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2014.05.014","article-title":"Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial","volume":"61","author":"Park","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0370","first-page":"CD007339","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2018.05.013_bib0375","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.lpm.2018.05.013_bib0380","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0385","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.lpm.2018.05.013_bib0390","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.lpm.2018.05.013_bib0395","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lpm.2018.05.013_bib0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.01.040","article-title":"Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"10.1016\/j.lpm.2018.05.013_bib0405","doi-asserted-by":"crossref","first-page":"e53719","DOI":"10.1371\/journal.pone.0053719","article-title":"Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial","volume":"8","author":"Spahr","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lpm.2018.05.013_bib0410","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2005.01.032","article-title":"Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis","volume":"43","author":"Sen","year":"2005","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.lpm.2018.05.013_bib0415","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","article-title":"Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis","volume":"38","author":"Jalan","year":"2003","journal-title":"J Hepatol"},{"issue":"Supple\u00a02","key":"10.1016\/j.lpm.2018.05.013_bib0420","doi-asserted-by":"crossref","first-page":"s355","DOI":"10.1016\/S0168-8278(08)60952-6","article-title":"Tolerance and efficacy of the mars system in patients with severe alcoholic hepatitis non-responders to steroids: a pilot study","volume":"48","author":"Boitard","year":"2008","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.lpm.2018.05.013_bib0425","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lpm.2018.05.013_bib0430","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.lpm.2018.05.013_bib0435","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2018.05.013_bib0440","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lpm.2018.05.013_bib0445","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/j.lpm.2018.05.013_bib0450","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2018.05.013_bib0455","doi-asserted-by":"crossref","DOI":"10.1002\/lt.25039","article-title":"for Groupe de Recherche Fran\u00e7ais en Greffe de Foie (GReF2). Impact of a first study of early transplantation in acute alcoholic hepatitis: results of a nationwide survey in French liver transplantation programs","author":"Antonini","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.lpm.2018.05.013_bib0460","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the United States\u2013a single-Center experience","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.lpm.2018.05.013_bib0465","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000001831","article-title":"Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis","volume":"265","author":"Lee","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.lpm.2018.05.013_bib0470","article-title":"Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lpm.2018.05.013_bib0475","doi-asserted-by":"crossref","first-page":"e0190823","DOI":"10.1371\/journal.pone.0190823","article-title":"Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis","volume":"13","author":"Marot","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2018.05.013_bib0480","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/liv.12939","article-title":"Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials","volume":"36","author":"Hmoud","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.lpm.2018.05.013_bib0485","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","author":"Gustot","year":"2014","journal-title":"J Hepatol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218302616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218302616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T01:58:35Z","timestamp":1571623115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498218302616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":97,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0755498218302616"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2018.05.013","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H\u00e9patite alcoolique aigu\u00eb s\u00e9v\u00e8re","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2018.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}